兔抗VHL多克隆抗體

Background:

Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity.

Applications:

ELISA, WB, IHC

Name of antibody:

VHL

Immunogen:

Full length fusion protein

Full name:

von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase

Synonyms：

RCA1; VHL1; pVHL; HRCA1

SwissProt:

P40337

ELISA Recommended dilution:

2000-5000

IHC positive control:

Human colon cancer and Human thyroid cancer

IHC Recommend dilution:

25-100

WB Predicted band size:

24 kDa

WB Positive control:

Human fetal brain tissue

WB Recommended dilution:

500-2000